EIKEN CHEMICAL CO.,LTD. (4549) Cash flow
Market cap
¥108B
P/E ratio
44.6x
Manufactures and sells diagnostic reagents for the medical field through operations in Japan and China, with plans to expand into the American market.
| 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | 2026/03 | |
| Depreciation & amortization | 1,253 | 1,430 | 1,563 | 1,660 | 1,594 | 1,627 | 1,711 | 2,058 | 2,125 | 2,326 | 2,554 | 2,536 |
| Cash from operations | 3,393 | 3,115 | 4,701 | 4,091 | 3,318 | 5,460 | 5,451 | 7,769 | 7,575 | 3,806 | 6,033 | 4,045 |
| Capital expenditures | -1,048 | -3,097 | -1,898 | -3,128 | -769 | -2,307 | -1,554 | -4,428 | -3,206 | -1,976 | -5,214 | -5,756 |
| Cash from investing | -6,652 | -3,737 | -1,876 | -3,250 | -4,435 | -3,711 | -2,193 | -5,044 | -316 | -2,216 | -4,499 | -3,423 |
| Payments for dividends | -674 | -694 | -732 | -1,007 | -937 | -1,106 | -1,180 | -1,699 | -2,033 | -1,927 | -1,799 | -1,858 |
| Repurchases of common stock | - | - | - | - | - | - | - | - | - | -4,707 | -2,675 | -1,675 |
| Proceeds from issuance of term debt, net | - | - | - | - | - | - | - | - | - | - | - | 3,000 |
| Repayments of term debt | -270 | - | - | - | - | - | - | - | - | - | - | -50 |
| Cash from financing | -1,107 | -869 | -910 | -1,175 | -1,083 | -1,220 | -1,275 | 1,200 | -2,095 | -6,694 | -4,857 | -322 |